Barrow Hanley Mewhinney Strauss buys $1,046,806,063 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Barrow Hanley Mewhinney Strauss scooped up 6,681,725 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 12,520,106 shares of Cardinal Health Inc which is valued at $1,046,806,063.Cardinal Health Inc makes up approximately 1.54% of Barrow Hanley Mewhinney Strauss’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Investment Partners S.a. boosted its stake in CAH in the latest quarter, The investment management firm added 153,506 additional shares and now holds a total of 504,651 shares of Cardinal Health Inc which is valued at $42,193,870. Cardinal Health Inc makes up approx 0.36% of Bnp Paribas Investment Partners S.a.’s portfolio.Exane Derivatives reduced its stake in CAH by selling 323 shares or 8.6% in the most recent quarter. The Hedge Fund company now holds 3,432 shares of CAH which is valued at $290,484. Cardinal Health Inc makes up approx 0.05% of Exane Derivatives’s portfolio.Robeco Institutional Asset Management B.v. reduced its stake in CAH by selling 41,622 shares or 8.96% in the most recent quarter. The Hedge Fund company now holds 423,004 shares of CAH which is valued at $35,105,102. Cardinal Health Inc makes up approx 0.26% of Robeco Institutional Asset Management B.v.’s portfolio.Leavell Investment Management boosted its stake in CAH in the latest quarter, The investment management firm added 73 additional shares and now holds a total of 47,343 shares of Cardinal Health Inc which is valued at $3,943,198. Cardinal Health Inc makes up approx 0.57% of Leavell Investment Management’s portfolio. Bkd Wealth Advisors sold out all of its stake in CAH during the most recent quarter. The investment firm sold 3,600 shares of CAH which is valued $296,208.

Cardinal Health Inc closed down -0.41 points or -0.49% at $83.19 with 13,92,896 shares getting traded on Monday. Post opening the session at $83.25, the shares hit an intraday low of $83.05 and an intraday high of $83.4929 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *